Please join us for a one-hour webinar to discuss the Food and Drug Administration's new final guidance on mobile medical applications.
Topics will include:
An overview of the differences between the draft and final guidance documents
The types of apps FDA intends to actively regulate and the types that are subject to enforcement discretion
Regulatory impact for software developers, mobile platform manufacturers, and others involved in the development and sale of mobile medical apps
Wednesday, October 9, 2013
12–1 pm ET
Elizabeth Bierman | Partner, Washington, D.C.
Tony Pavel | Partner, Washington, D.C.
Michele Buenafe | Associate, Washington, D.C.
CLE credit in CA, NJ, NY, PA, and TX is pending approval.